RT Journal Article
SR Electronic
T1 Simulation of aerosol and droplet spread during upper airway and gastrointestinal endoscopy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.20.21255743
DO 10.1101/2021.04.20.21255743
A1 Johannes Heymer
A1 Florian Dengler
A1 Alexander Krohn
A1 Christina Jaki
A1 Tobias Schilling
A1 Martina Müller-Schilling
A1 Arne Kandulski
A1 Matthias Ott
YR 2021
UL http://medrxiv.org/content/early/2021/04/20/2021.04.20.21255743.abstract
AB Objective Aerosols and droplets are the main vectors in transmission of highly contagious SARS-Cov-2. Invasive diagnostic procedures like upper airway and gastrointestinal endoscopy have been declared as aerosol generating procedures. Protection of health care workers is crucial in times of COVID-19 pandemic.Methods We simulated aerosol and droplet spread during upper airway and gastrointestinal endoscopy with and without physico-mechanical barriers using a simulation model.Results A clear plastic drape as used for central venous access markedly reduced visualized aerosol and droplet spread during endoscopy.Conclusion A simple and cheap drape has the potential to reduce aerosol and droplet spread during endoscopy. In terms of health care worker protection, this may be important particularly in low- or moderate-income countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIncluded / on request.